Saturday, November 18, 2017

Eris signs definitive pact to buy Strides' India portfolio for Rs 500 cr

MAPE Advisory Group and Tatva Legal acted as advisors for Strides in the deal, while EY India and Shardul Amarchand Mangaldas & Co advised Eris Lifesciences on this transaction. Founded in 1990, Strides manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals.

more here

No comments:

Post a Comment